Skip to main content

Table 2 Comparisons between subgroups with concentric wall thickening and non-concentric wall thickening

From: Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease

 

Concentric wall thickening (n = 17)

Non-concentric wall thickening (n = 5)

Statistical significance (p-value)

Males

12 (71 %)

3 (60 %)

1.000

Age (years)

49.4 (44.1–53.9)

62.2 (51.2–63.8)

0.055

Hypertension

5 (29 %)

4 (80 %)

0.115

EDWTmax (mm)

14.4 (13.3–16.5)

17.3 (16.5–31.0)

0.017

LVEDVI (ml/m2)

83.6 (74.1–108.6)

78.0 (76.4–94.8)

0.845

LVEF (%)

59.3 (56.3–64.6)

57.4 (56.0–66.7)

0.969

LVMI (g/m2)

91.5 (77.2–103.1)

132.7 (93.1–174.7)

0.066

LVPMI (g/m2)

4.8 (3.6–6.4)

5.6 (4.9–9.1)

0.147

LVTPMI ml/m2)

13.8 (10.1–17.0)

20.2 (15.5–22.6)

0.066

Scar as percentage of total LV myocardium (%)

2.8 (1.3–7.0)

14.7 (7.1–21.8)

0.026

Scar as percentage of apical myocardium (%)

0.3 (0.0–1.1)

18.9 (14.4–40.6)

0.003

Scar as percentage of mid-ventricular myocardium (%)

2.0 (1.0–5.2)

9.1 (6.8–21.9)

0.014

Scar as percentage of basal myocardium (%)

4.4 (1.1–8.1)

5.3 (1.4–13.8)

0.411

  1. All data are provided as numbers, percentages or interquartile range where appropriate
  2. EDWTmax Maximum end-diastolic wall thickness, LVMI Indexed left ventricular mass (excluding papillary muscles), LVPMI Indexed left ventricular papillary mass, LVTPMI Indexed left ventricular trabecular and papillary muscle volume, LVEDVI Indexed left ventricular end-diastolic volume, LVEF Left ventricular ejection fraction